Gainers

  • Inventiva IVA stock increased by 11.2% to $4.19 during Wednesday's after-market session. The company's market cap stands at $176.1 million.
  • Bluejay Diagnostics BJDX shares increased by 8.84% to $5.17. Bluejay Diagnostics's trading volume hit 5.4 million shares by close, accounting for 921.8% of its average volume over the last 100 days. The company's market cap stands at $6.4 million.
  • Xilio Therapeutics XLO shares rose 8.4% to $2.45. The market value of their outstanding shares is at $67.4 million.
  • Marinus Pharma MRNS shares increased by 7.71% to $7.75. The company's market cap stands at $392.2 million.
  • Dare Bioscience DARE stock moved upwards by 7.49% to $0.49. The company's market cap stands at $48.0 million.
  • Alzamend Neuro ALZN shares increased by 7.26% to $0.25. The market value of their outstanding shares is at $23.9 million.

Losers

  • Great Elm Group GEG stock decreased by 14.7% to $1.86 during Wednesday's after-market session. The company's market cap stands at $56.9 million. The company's, Q4 earnings came out today.
  • 4D Molecular Therapeutics FDMT stock fell 6.9% to $13.5. The company's market cap stands at $567.7 million.
  • Perspective Therapeutics CATX stock fell 6.6% to $0.28. The company's market cap stands at $78.6 million.
  • Avinger AVGR shares decreased by 6.46% to $12.9. Avinger's trading volume hit 2.3 million shares by close, accounting for 183.4% of its average volume over the last 100 days. The company's market cap stands at $8.0 million.
  • Soligenix SNGX shares decreased by 6.27% to $0.48. The company's market cap stands at $4.7 million.
  • Oragenics OGEN stock decreased by 6.01% to $2.82. The market value of their outstanding shares is at $7.1 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Market News and Data brought to you by Benzinga APIs

Posted In:
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!